Search by Drug Name or NDC
NDC 00713-0937-01 cevimeline hydrochloride 30 mg/1 Details
cevimeline hydrochloride 30 mg/1
cevimeline hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is CEVIMELINE HYDROCHLORIDE.
Product Information
| NDC | 00713-0937 |
|---|---|
| Product ID | 0713-0937_f183f958-57f5-ea10-e053-2995a90a5ead |
| Associated GPIs | |
| GCN Sequence Number | 044913 |
| GCN Sequence Number Description | cevimeline HCl CAPSULE 30 MG ORAL |
| HIC3 | J1A |
| HIC3 Description | PARASYMPATHETIC AGENTS |
| GCN | 12624 |
| HICL Sequence Number | 021080 |
| HICL Sequence Number Description | CEVIMELINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | cevimeline hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cevimeline hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | CEVIMELINE HYDROCHLORIDE |
| Labeler Name | Cosette Pharmaceuticals, Inc. |
| Pharmaceutical Class | Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020989 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00713-0937-01 (00713093701)
| NDC Package Code | 0713-0937-01 |
|---|---|
| Billing NDC | 00713093701 |
| Package | 100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0937-01) |
| Marketing Start Date | 2023-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.95744 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CEVIMELINE HCL 30 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis